dc.contributor.author | Parker, C | |
dc.contributor.author | Gillessen, S | |
dc.contributor.author | Horwich, A | |
dc.contributor.author | ESMO Guidelines Committee | |
dc.date.accessioned | 2017-03-01T11:12:08Z | |
dc.date.issued | 2016-09 | |
dc.identifier.citation | Annals of oncology : official journal of the European Society for Medical Oncology, 2016, 27 (suppl 5), pp. v146 - v147 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/411 | |
dc.identifier.eissn | 1569-8041 | |
dc.identifier.doi | 10.1093/annonc/mdw361 | |
dc.format | Print | |
dc.format.extent | v146 - v147 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.subject | ESMO Guidelines Committee | |
dc.title | appendix 8: Prostate cancer: eUpdate published online September 2016 (https://www.esmo.org/Guidelines/Genitourinary-Cancers). | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2016-09-01 | |
rioxxterms.versionofrecord | 10.1093/annonc/mdw361 | |
rioxxterms.licenseref.startdate | 2016-09 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Annals of oncology : official journal of the European Society for Medical Oncology | |
pubs.issue | suppl 5 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 27 | en_US |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Parker, Chris | |